|
|
Article: Idenix Pharmaceuticals, Inc. - Financial and Strategic Analysis Review.
- Article from:
- M2 Presswire
- Article date:
- May 6, 2009
CopyrightCOPYRIGHT 2009 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-6 May 2009-www.companiesandmarkets.com: Idenix Pharmaceuticals, Inc. - Financial and Strategic Analysis Review(C)1994-2009 M2 COMMUNICATIONS LTD
RDATE:06052009
-www.companiesandmarkets.com adds new report: Idenix Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Idenix Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Summary
Idenix Pharmaceuticals, Inc. is a specialized biopharmaceutical company focused in the areas of human viral and other infectious diseases. The company is engaged in the discovery and development of treatments for HCV and HIV. Idenix under its co-development ...
Related newspaper, magazine, and journal articles:
|
|
Article: Idenix Pharmaceuticals, Inc. Appoints Former Merck ...
PR Newswire;
September 18, 2003 ;
700+ words
... ... Sept. 18 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. today announced that it ... US and Europe." About Idenix: Idenix Pharmaceuticals, Inc. is a biopharmaceutical ... www.idenix.com/. Contact: Idenix Pharmaceuticals, Inc. Euro RSCG Life NRP (617 ...
|
|